Possible mechanism of central nervous system targeting and neurological symptoms of the new-coronavirus (COVID-19): literature review

Jumagaliyeva M. Ayaganov D. Saparbayev S. Tuychibaeva N. Abdelazim I.A. Kurmambayev Y. Khamidullina Z. Yessenamanova S.
2023 Verduci Editore s.r.l

European Review for Medical and Pharmacological Sciences
2023 #27 Issue 19 9420 - 9428 pp.

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that caused the 2019 Coronavirus Disease (COVID-19) has been associated with several neurological symptoms. This review aimed to highlight the possible mechanism of central nervous system (CNS) targeting and the neurological symptoms that may occur with the COVID-19 infection. The case reports containing the keywords “neurological symptoms” and “COVID-19” were thoroughly reviewed to identify possible mechanisms of CNS targeting and neurological manifestations associated with COVID-19 infection. The angiotensin-converting enzyme-2 (ACE2) receptors have been identified as the functional receptor for SARS-CoV-2. SARS-CoV-2 can affect the CNS through the following mechanisms: 1) Direct infection. 2) Blood pathway. 3) Neuronal pathway. 4) Immune-mediated injury/pathway (Cytokine Storm Syndrome). COVID-19 virus, a neurotropic virus, was isolated from the cerebral fluid (CSF) and responsible for several neurological manifestations. The COVID-19 infection primarily affects CD4+ and CD8+ T-lymphocytes and it induces a surge of inflammatory cytokines, known as Cytokine Storm Syndrome (CSS). The Interlukine-6 (IL-6) is the primary CSS component. The IL-6, interferon-γ and endothelial growth factor were significantly higher in COVID-19 infected compared to non-infected individuals. The improvement of the COVID-19 patients after interleukin receptor blockers supports the CSS theory. The spectrum of SARS-CoV-2 neurological manifestations includes encephalitis, viral meningitis, post-COVID-19 infectious acute disseminated encephalitis, Guillain-Barré Syndrome (GBS), Miller-Fisher syndrome (MFS) and acute cerebrovascular disease (CVD). Several COVID-19-associated neurological manifestations have been reported. Thus, it is important to identify and treat neurological symptoms as soon as possible to avoid long-term effects. The care providers should take the appropriate preventive precautions because patients can present with neurological manifestations of COVID-19 without any respiratory symptoms. Future research is warranted to confirm the relationship between SARS-CoV-2 and the development of neurological manifestations.

Central nervous system , COVID-19 , Neurological symptoms , New coronavirus

Text of the article Перейти на текст статьи

Department of Neurology, Psychiatry and Narcology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
Department of Normal Physiology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
Department of Neurology, Psychology and Psychotherapy, Tashkent Medical Academy, Tashkent, Uzbekistan
Department of Obstetrics and Gynecology, Faculty of Medicine Ain Shams University, Egypt
Department of Obstetrics and Gynecology N. 1, Astana Medical University, Astana, Kazakhstan
Department ofObstetrics and Gynecology N. 1, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan

Department of Neurology
Department of Normal Physiology
Department of Neurology
Department of Obstetrics and Gynecology
Department of Obstetrics and Gynecology N. 1
Department ofObstetrics and Gynecology N. 1

10 лет помогаем публиковать статьи Международный издатель

Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026